Tyndall Capital Partners L P

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Cyclerion Therapeutics, Inc.
CYCN
$527,286.006.08164,777+0.21%+$1,113.60100
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.